Session: Young Injection Drug Users Poster Session
4095.0: Tuesday, November 18, 2003: 12:30 PM-2:00 PM
Poster
Young Injection Drug Users Poster Session
Learning Objectives: Refer to the individual abstracts for learning objectives
See individual abstracts for presenting author's disclosure statement and author's information.
Board 1Demographic characteristics and drug practices of young injection drug users from suburban and urban Chicago
Matthew J Magee, BA, Lawrence Ouellet, PhD, Joyce M Fitzgerald, BA, Susan L Bailey, PhD
Board 2Drug risk behaviors and HIV testing behavior among adolescents and young adults
Grace L. Reynolds, DPA(c), Jennifer A. Klahn, MA, Catherine M. Branson, BA, Dennis G. Fisher, PhD
Board 3Incarceration and risk for HIV and hepatitis in young injectors
Wanitchaya Kittikraisak, MS, Kimberly Page-Shafer, PhD, Paula J Lum, MD, Judy Hahn, PhD, Jennifer Evans, MS, Peter J Davidson, BA, Andrew R Moss, PhD
Board 4Overdose among young "urban nomad" injection drug users (IDUs)
Theresa Perlis, PhD, Don C. Des Jarlais, Joy Settembrino
Board 5Predictors of hepatitis B virus infection among young street-recruited injection drug users in San Francisco, the UFO Study
Paula J Lum, MD MPH, Kimberly Page Shafer, PhD, Judith A Hahn, PhD, Jennifer Evans, MS, Peter J Davidson, BA, Ellen Stein, MPH, Andrew R Moss, PhD
Board 6Preventing hepatitis C virus (HCV) infection in young injection drug users (IDUs): An assessment of opportunities for intervention
Lawrence J. Ouellet, PhD, Susan L. Bailey, PhD
Board 7Young suburban injection drug users (IDUs) in metropolitan Chicago are a potential bridge population for HIV and other sexually transmitted infections (STIs)
Dita A. Davis, Susan L. Bailey, PhD, Lawrence J. Ouellet, PhD
Board 8Youth outreach educators: Peer driven interventions for young injection drug users in Chicago
Karen A. Stanczykiewicz
Board 9HIV and HCV-related risk behaviors among young incarcerated IDUs
Edward V Morse, PhD, Patricia Morse, LCSW, PhD, Charles C Foti, JD
Board 10A national survey of drug treatment program directors’ beliefs about HCV service provision
Janetta Astone, PhD, Shiela M. Strauss, PhD, Holly Hagan, PhD, Don C Des Jarlais, PhD
Organized by:Alcohol, Tobacco, and Other Drugs

The 131st Annual Meeting (November 15-19, 2003) of APHA